Clinical Trial

A Long-term Observational Study in Participants Who Have Received PBGENE-HBV

Study acronym: ELIMINATE-B
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-19.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-04-21
Trial Details
NCT Number NCT07254208
Lead Sponsor Precision BioSciences, Inc.
Conditions Chronic HBV Infection
Enrollment 45 participants
Start Date 2025-12-25
Primary Completion 2040-01 (estimated)
Study Completion 2040-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-22